ISDS

More than 80% reduction in disease activity in case series of tofacitinib treatment

About 30% of patients had 75% clearance after 6 months, half had 50% clearance

Inhibition of Th2-related inflammation leads to rapid improvement in disease activity

Rapid, persistent improvement in body surface area, itch, other symptoms with roflumilast

Study looks at costimulatory blockade with abatacept after stopping ustekinumab

But hypothesis regarding sodium chloride levels in skin needs more work, expert says

Protein analysis may help differentiate between eczema, psoriasis

Effectiveness of agent against atopic dermatitis also makes eyes vulnerable